市场调查报告书
商品编码
1516430
心臟监测和心律管理设备的全球市场 2024-2028Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market 2024-2028 |
心臟监测和心律管理设备市场预计在2023-2028年期间将达到74.7672亿美元,预测期内复合年增长率为5.38%。
该报告对心臟监测和心律管理设备市场进行了全面分析,包括市场规模和预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析。
它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。该市场的推动因素包括全球 CVDS 的日益普及、CM 和 CRM 设备的技术进步以及行动心电遥测(MCT) 的日益普及。
市场范围 | |
---|---|
基准年 | 2024年 |
结束年份 | 2028年 |
预测期 | 2024-2028 |
成长动力 | 加速度 |
2024年与前一年同期比较 | 4.44% |
复合年增长率 | 5.38% |
增量 | 747,672 万美元 |
研究指出,供应商不断增加的策略倡议是推动未来几年心臟监测和心律管理设备市场成长的关键因素。此外,对整合心律不整监测设备开发的日益关注以及心臟植入使用的增加也将带来巨大的市场需求。
The cardiac monitoring and cardiac rhythm management devices market is forecasted to grow by USD 7476.72 mn during 2023-2028, accelerating at a CAGR of 5.38% during the forecast period. The report on the cardiac monitoring and cardiac rhythm management devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cvds globally, technological advances in cm and crm devices, and increasing uptake of mobile cardiac telemetry (mct).
Technavio's cardiac monitoring and cardiac rhythm management devices market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 4.44% |
CAGR | 5.38% |
Incremental Value | $7476.72mn |
By Product
By End-user
By Geography
This study identifies the increasing strategic initiatives by market vendors as one of the prime reasons driving the cardiac monitoring and cardiac rhythm management devices market growth during the next few years. Also, growing focus on developing integrated arrhythmia-monitoring devices and increasing utilization of cardiac implants will lead to sizable demand in the market.
The report on the cardiac monitoring and cardiac rhythm management devices market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiac monitoring and cardiac rhythm management devices market vendors that include Abbott Laboratories, Adaptive Biotechnologies Corp., Asahi Kasei Corp., BIOTRONIK SE and Co. KG, Boston Scientific Corp., BPL MEDICAL TECHNOLOGIES Pvt. Ltd., Cell Microsystems Inc., GE Healthcare Technologies Inc., Johnson and Johnson, Koninklijke Philips N.V., Medtronic Plc, MicroPort Scientific Corp., Nihon Kohden Corp., Osypka Medical GmBH, Progetti srl, QIAGEN NV, SCHILLER AG, Stryker Corp., ZOLL Medical Corp., and Shree Pacetronix Ltd.. Also, the cardiac monitoring and cardiac rhythm management devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: